Oncotarget

Vol 12, No 1

January 5, 2021

View Archive »

Order a Reprint

About The Cover

The cover for issue 1 of Oncotarget features Figure 2, "Results in clinical trials," by Blagoev, et al.

Table of Contents

Editorial

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors

https://doi.org/10.18632/oncotarget.27861

Erika J. Crosby, H. Kim Lyerly,  and Zachary C. Hartman
1-3
PDF  |  How to cite  |  Order a Reprint

Carving a niche for immunotherapy in ovarian cancer

Carving a niche for immunotherapy in ovarian cancer

https://doi.org/10.18632/oncotarget.27864

Nitasha Gupta, Erika Lampert,  and Jung-Min Lee
4-7
PDF  |  How to cite  |  Order a Reprint

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy

https://doi.org/10.18632/oncotarget.27865

Adam M. Sonabend, Roger Stupp, Catalina Lee-Chang,  and Hideho Okada
8-9
PDF  |  How to cite  |  Order a Reprint

Research Perspectives

Combination therapies for MPNSTs targeting RABL6A-RB1 signaling

Combination therapies for MPNSTs targeting RABL6A-RB1 signaling

https://doi.org/10.18632/oncotarget.27862

Jordan L. Kohlmeyer, David J. Gordon, Munir R. Tanas, Rebecca D. Dodd, Varun Monga, Benjamin W. Darbro,  and Dawn E. Quelle
10-14
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Research Papers

Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer

Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer

https://doi.org/10.18632/oncotarget.27855

Krastan B. Blagoev, Roumen Iordanov, Mengxi Zhou, Tito Fojo,  and Susan E. Bates
15-21
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment

Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment

https://doi.org/10.18632/oncotarget.27859

Juyeon Ko, April N. Meyer, Martin Haas,  and Daniel J. Donoghue
22-36
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model

Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model

https://doi.org/10.18632/oncotarget.27857

Gerrit Spanier, Daniela Weidt, Dirk Hellwig, Johannes K.H. Meier, Torsten E. Reichert,  and Jirka Grosse
37-48
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation

The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation

https://doi.org/10.18632/oncotarget.27858

Karim Abid, Maja Beck Popovic, Katia Balmas Bourloud, Jacqueline Schoumans, Joana Grand-Guillaume, Eric Grouzmann,  and Annick Mühlethaler-Mottet
49-60
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals

Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals

https://doi.org/10.18632/oncotarget.27638

Pengjun Zhou, Rong Zhang, Ying Wang, Dandan Xu, Li Zhang, Jinhong Qin, Guifeng Su, Yue Feng, Hongce Chen, Siyuan You, Wen Rui, Huizhong Liu, Suhong Chen, Hongyuan Chen,  and Yifei Wang
61-62
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC